Comments on Proposed Rule Regarding Approach to PFAS Reporting Requirements and Supplier Notification for Chemicals of Special Concern Share page: Docket Number: EPA–HQ–TRI–2022–0270 Download Document Issues: OTC Medicines Dietary Supplements Consumer Medical Devices Other Issues Packaging Sustainability PFAS Related Posts Press Releases and Statements Citizen Petition Urges FTC to Immediately Withdraw Notice of Penalty Offenses Sent to Hundreds of Consumer Healthcare Companies Sep 15, 2023 Press Releases and Statements Statement Following the September 2023 Meeting of the Nonprescription Drugs Advisory Committee (NDAC) to Evaluate New Data Concerning the Efficacy of Oral PE Sep 12, 2023 Press Releases and Statements Statement on the Sept. 11-12, 2023, Meeting of the FDA NDAC to Evaluate the Efficacy of Oral PE Sep 7, 2023